Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Specialties
  • Urology
  • Page 6
Testosterone Therapy in Middle-Aged and Older Men with Hypogonadism: Balancing Clinical Benefits and Risks
Posted inClinical Updates news Specialties Urology

Testosterone Therapy in Middle-Aged and Older Men with Hypogonadism: Balancing Clinical Benefits and Risks

Posted by MedXY By MedXY 08/07/2025
Testosterone therapy offers modest benefits for sexual function, anemia, and bone health in older men with hypogonadism, but increases risks of venous thromboembolism, fractures, and arrhythmias. Careful patient selection and individualized risk-benefit assessment are essential.
Read More
Symptoms of Pelvic Inflammatory Disease: The Three Most Distinctive Signs
Posted innews Specialties Urology

Symptoms of Pelvic Inflammatory Disease: The Three Most Distinctive Signs

Posted by MedXY By MedXY 08/06/2025
Pelvic inflammatory disease (PID) commonly presents with lower abdominal pain, abnormal vaginal discharge, and systemic symptoms like fever. Early recognition and treatment are vital to prevent complications.
Read More
Serenoa repens (Saw Palmetto) in Benign Prostatic Hyperplasia: Clinical Evidence and Implications for Practice
Posted innews Specialties Urology

Serenoa repens (Saw Palmetto) in Benign Prostatic Hyperplasia: Clinical Evidence and Implications for Practice

Posted by MedXY By MedXY 08/06/2025
Recent high-quality evidence indicates that Serenoa repens provides little to no benefit for lower urinary tract symptoms due to benign prostatic enlargement compared to placebo.
Read More
Can Kidney Stone Sufferers Safely Take Calcium Supplements? Unveiling the Truth
Posted innews Specialties Urology

Can Kidney Stone Sufferers Safely Take Calcium Supplements? Unveiling the Truth

Posted by MedXY By MedXY 08/06/2025
Exploring the relationship between calcium intake and kidney stones, this article provides evidence-based guidance for patients and health professionals.
Read More
Enfortumab Vedotin Plus Pembrolizumab vs Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer: Patient-Reported Outcomes from the EV-302 Phase 3 Study
Posted inClinical Updates news Oncology Specialties Urology

Enfortumab Vedotin Plus Pembrolizumab vs Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Cancer: Patient-Reported Outcomes from the EV-302 Phase 3 Study

Posted by MedXY By MedXY 08/03/2025
The EV-302 trial shows enfortumab vedotin plus pembrolizumab improves survival and quality of life over platinum-based chemotherapy in untreated advanced urothelial cancer patients.
Read More
Early Toxicity Comparison of Moderately Hypofractionated Radiotherapy and Stereotactic Body Radiotherapy in Prostate Cancer: Insights from the PACE-C Trial
Posted inClinical Updates news Oncology Radiology Specialties Urology

Early Toxicity Comparison of Moderately Hypofractionated Radiotherapy and Stereotactic Body Radiotherapy in Prostate Cancer: Insights from the PACE-C Trial

Posted by MedXY By MedXY 08/03/2025
The PACE-C phase 3 trial shows that stereotactic body radiotherapy (SBRT) and moderately hypofractionated radiotherapy (MHRT) have comparable early toxicity profiles in intermediate- and high-risk prostate cancer patients.
Read More
Cabozantinib Plus Atezolizumab in mCRPC: CONTACT-02 Phase 3 Final Results and Clinical Implications
Posted inClinical Updates news Oncology Specialties Urology

Cabozantinib Plus Atezolizumab in mCRPC: CONTACT-02 Phase 3 Final Results and Clinical Implications

Posted by MedXY By MedXY 08/02/2025
The CONTACT-02 phase 3 trial shows cabozantinib plus atezolizumab improves progression-free survival but not overall survival in advanced mCRPC post-ARPI, offering a novel non-androgen receptor-based option.
Read More
Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial
Posted inClinical Updates Infectious Diseases news Specialties Urology

Individualised Versus Standard 10-Day Antibiotic Therapy in Pediatric Febrile UTI: Insights from the INDI-UTI Trial

Posted by MedXY By MedXY 08/02/2025
A Danish multicentre trial found individualised, shorter antibiotic regimens for febrile pediatric UTIs reduce overall antibiotic exposure and adverse events, but with a modestly higher recurrence risk compared to standard 10-day treatment.
Read More
Doxycycline Post-Exposure Prophylaxis Significantly Reduces Bacterial STIs Among MSM and Transgender Women: Final Results from the DoxyPEP Trial
Posted inClinical Updates HIV/AIDS news Specialties Urology

Doxycycline Post-Exposure Prophylaxis Significantly Reduces Bacterial STIs Among MSM and Transgender Women: Final Results from the DoxyPEP Trial

Posted by MedXY By MedXY 08/02/2025
The DoxyPEP trial demonstrates that doxycycline post-exposure prophylaxis markedly lowers bacterial STI incidence in men who have sex with men and transgender women, with good tolerability and minimal resistance over 12 months.
Read More
Metformin in Prostate Cancer: Revisiting Hopes and Realities After Recent Phase 3 Trials
Posted inClinical Updates news Oncology Specialties Urology

Metformin in Prostate Cancer: Revisiting Hopes and Realities After Recent Phase 3 Trials

Posted by MedXY By MedXY 08/02/2025
Recent large RCTs show metformin does not improve survival or reduce metabolic syndrome risk in prostate cancer patients on ADT, though it modestly improves metabolic parameters.
Read More
First-in-Human Results of Terbium-161 PSMA Radioligand Therapy in mCRPC: Insights from the VIOLET Study
Posted inClinical Updates news Oncology Specialties Urology

First-in-Human Results of Terbium-161 PSMA Radioligand Therapy in mCRPC: Insights from the VIOLET Study

Posted by MedXY By MedXY 08/02/2025
A phase 1/2 trial demonstrates the safety of [161Tb]Tb-PSMA-I&T, a novel dual beta-Auger radioligand, in heavily pretreated metastatic castration-resistant prostate cancer patients, supporting further clinical investigation.
Read More
How to Make Urology Care More Comfortable for Women
Posted innews OB/GYN & Women's Health Specialties Urology

How to Make Urology Care More Comfortable for Women

Posted by MedXY By MedXY 07/30/2025
Exploring why women often feel discomfort during urology visits and actionable strategies to create a more welcoming, effective clinical experience.
Read More
Understanding and Preventing Prostatitis: What Every Man Should Know and Do
Posted innews Specialties Urology

Understanding and Preventing Prostatitis: What Every Man Should Know and Do

Posted by MedXY By MedXY 07/27/2025
Prostatitis is common and often misunderstood. Learn the latest science, dispel myths, and discover practical steps to keep your prostate healthy.
Read More
Does More Sex Mean a Longer Life? The Surprising Science Behind Sexual Activity and Longevity
Posted inFamily Medicine & Nutrition news OB/GYN & Women's Health Specialties Urology

Does More Sex Mean a Longer Life? The Surprising Science Behind Sexual Activity and Longevity

Posted by MedXY By MedXY 07/26/2025
Exploring whether more frequent sex truly leads to a longer life, this article examines scientific evidence, dispels myths, and offers practical sexual wellness advice for couples.
Read More
When Sex Ends Without Ejaculation: Understanding Ejaculatory Dysfunction
Posted inFamily Medicine & Nutrition news Urology

When Sex Ends Without Ejaculation: Understanding Ejaculatory Dysfunction

Posted by MedXY By MedXY 07/26/2025
Persistent inability to ejaculate during sex may indicate ejaculatory dysfunction, a common but often misunderstood men's health issue. This article explores causes, myths, and practical steps for care.
Read More
Treating Chronic Prostatitis: Why Subtyping Matters for Effective Care
Posted innews Specialties Urology

Treating Chronic Prostatitis: Why Subtyping Matters for Effective Care

Posted by MedXY By MedXY 07/26/2025
Chronic prostatitis is complex and requires tailored treatment based on its specific subtype. Learn why accurate diagnosis is key for better outcomes.
Read More
Guarding the ‘Life Gland’: What Every Man Should Know About Prostate Health
Posted innews Urology

Guarding the ‘Life Gland’: What Every Man Should Know About Prostate Health

Posted by MedXY By MedXY 07/26/2025
Explore the vital role of the prostate, common misconceptions, science-backed practices, and expert insights to safeguard men's health at every age.
Read More
From Boyhood to Manhood: Recognizing and Addressing Pubertal Developmental Disorders
Posted innews Urology

From Boyhood to Manhood: Recognizing and Addressing Pubertal Developmental Disorders

Posted by MedXY By MedXY 07/26/2025
Explore the science, warning signs, and practical advice on abnormal male puberty, bridging knowledge for families and clinicians.
Read More
Frequent Urination After Drinking Water vs. Rare Bathroom Breaks: Which Is Healthier?
Posted innews Specialties Urology

Frequent Urination After Drinking Water vs. Rare Bathroom Breaks: Which Is Healthier?

Posted by MedXY By MedXY 07/26/2025
Does urinating often after drinking water mean better health? This article explores hydration, bladder habits, and what science says about bathroom frequency.
Read More
Can Erectile Dysfunction Recover on Its Own? Science, Myths, and Practical Guidance
Posted innews Urology

Can Erectile Dysfunction Recover on Its Own? Science, Myths, and Practical Guidance

Posted by MedXY By MedXY 07/26/2025
Explore whether erectile dysfunction can resolve naturally, the science behind recovery, and evidence-based strategies for optimal sexual health.
Read More

Posts pagination

Previous page 1 … 4 5 6
  • AI-Driven Prognosis: EEGSurvNet Accurately Predicts Seizure Timing From Routine EEG Data
  • Mammography Screening and Mortality: A 40-Year European Population-Based Evaluation Shows Shift to Early-Stage Detection
  • NEOS2 Score: A Precision Tool for Predicting Treatment Response and Three-Year Functional Recovery in Anti-NMDAR Encephalitis
  • Minor Papillotomy for Pancreas Divisum: The SHARP Trial Challenges Decades of Endoscopic Practice
  • Group Therapy for Prolonged Grief in Older Adults Proves Noninferior to Individual CBT
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in